The event will highlight techniques used to develop safe, differentiated, and efficacious therapies to pass through regulatory hurdles and provide an opportunity to analyze developments in bringing iPSC-derived immunotherapies from bench to bedside to deliver long-lasting, safe, effective therapeutics.
Back to All Events
Earlier Event: October 18
Process Development for Cell Therapies Summit
Later Event: October 18
The NYSCF Annual Conference